HIGHLIGHTS
- What: The authors provide of successfully treating late-onset RA (LORA) with baricitinib emphasizing the importance of tailoring treatment to unique clinical conditions.
- Who: Case report et al. from the Department of Rheumatology Clinical Immunology, Clinical hospital center Rijeka University of Rijeka, Faculty of Medicine Rijeka have published the research: Case report, in the Journal: (JOURNAL)
SUMMARY
RA can occur in the elderly and may present unique challenges in terms of management. The overall prevalence of polypharmacy in patients aged 75-84 years is 36.4% (95% CI 35.4-37 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.